My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Researchers have successfully created a novel biomaterial that can be seeded with insulin-producing beta cells. Implantation of the beta cell-seeded biomaterial reversed diabetes in a mouse model by effectively normalizing glucose levels and significantly increasing survival.
I have a strong affinity for the sciences which led me to create my sites. My compulsion for the past decade has been reviewing literally every peer-reviewed research article. Which can easily be validated by following my posts. To me, science is where the real news is, as it will mold our destiny beyond that of politics or economics. ;-)
Subscribe now to keep reading and get access to the full archive.
[…] via Type 1 Diabetes Reversed with New Beta Cell Implant (Animal Model) — ClinicalNews […]